Sara Byron
3Patents
2h-index
9Co-inventors
37Inventor score
Filing activity: Mar 14, 2011 → Aug 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9140689B2 | Methods of determining susceptibility of tumors to tyrosine kinase inhibitors | Physics | 5 | Active |
| US11186875B2 | Targeted therapies for cancer | Physics | 2 | Active |
| US11866789B2 | Targeted therapies for cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.